Table 2.
Determination of residual level anticoagulant drug.
Mean | SD | Median | Minimum | Maximum | |
---|---|---|---|---|---|
Dabigatran | 88.98 | 64.55 | 64.46 | 5.70 | 257.76 |
Dabigatran—DOAC-Stop | 0.60 | 0.73 | 0.31 | 0.00 | 2.70 |
Dabigatran—% reduction | 99.5 | 0.4 | 99.5 | 98.6 | 100.0 |
Rivaroxaban | 79.38 | 72.32 | 61.01 | 0.94 | 256.68 |
Rivaroxaban—DOAC-Stop | 1.46 | 2.53 | 0.75 | 0.00 | 10.97 |
Rivaroxaban—% reduction | 97.9 | 2.3 | 98.9 | 91.0 | 100.0 |
Apixaban | 92.47 | 69.88 | 71.23 | 20.51 | 324.73 |
Apixaban—DOAC-Stop | 2.72 | 3.83 | 1.26 | 0.00 | 13.03 |
Apixaban—% reduction | 97.1 | 3.4 | 98.2 | 88.9 | 100.0 |
Abbreviations: DOAC, direct oral anticoagulant; SD, standard deviation.